Impact of Clinical Pharmacist led-Educational program on Knowledge and Practice of Sudanese Pediatricians About Management of Epilepsy in Children

Authors

  • Salma Eltahir Doctor of Clinical Pharmacy, Wad Medani Pediatric Teaching Hospital, Ministry of Health, Gezira State, Sudan
  • Haydar Babikir Consultant Paediatric Neurologist, Department of Paediatrics and Child Health, University of Gezira, Sudan
  • Imad Taj Eldin Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Sudan

DOI:

https://doi.org/10.59652/sxv0xa19

Keywords:

Epilepsy, guidelines, protocols, Education, pharmcist

Abstract

Background: Epilepsy is one of the most common neurological disorders in children. Seizure frequency is an important indicator of treatment effectiveness. This study assessed the impact of a clinical pharmacist-led educational program on the knowledge and practice of pediatricians regarding the management of epilepsy in children. Methods: This was a pre-post interventional hospital-based study conducted at Wad Medani Pediatric Teaching Hospital from February 2022 to August 2023. Prescribers working at the hospital were included. Results: Wilcoxon signed-rank testing showed statistically significant differences in knowledge regarding the recommended route of administration of midazolam for acute seizures (p = 0.022) and discontinuation of chronic sodium valproate in seizure-free children (p = 0.016). A statistically significant difference was also observed in practice regarding planning the overall tapering period of antiseizure drugs (ASDs) in seizure-free patients (p = 0.016). Conclusion: The clinical pharmacist-led educational program improved selected aspects of knowledge and practice among prescribers managing childhood epilepsy.

 

Downloads

Download data is not yet available.

References

1. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-82.

2. Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020;54(2):185-91.

3. Bashir MBA, Cumber SN. The quality of life and inequalities in health services for epilepsy treatment among patience in the urban cities of Sudan. Pan Afr Med J. 2019;33:10.

4. Ernawati I, Yasin NM, Setyopranoto I, Ikawati Z. The role of pharmacists’ interventions in increasing medication adherence of patients with epilepsy: a scoping review. J Prev Med Public Health. 2024;57(3):212-22.

5. Deonna T. Management of epilepsy. Arch Dis Child. 2005;90(1):5-10.

6. van de Vrie-Hoekstra NW, de Vries TW, van den Berg PB, Brouwer OF, de Jong-van den Berg LTW. Antiepileptic drug utilization in children from 1997-2005: a study from the Netherlands. Eur J Clin Pharmacol. 2008;64(10):1013-20.

7. Kwong KL, Tsui KW, Wu SP, Yung A, Yau E, Eva F, et al. Utilization of antiepileptic drugs in Hong Kong children. Pediatr Neurol. 2012;46(5):281-6.

8. Cho YS, Ah YM, Jung AH, Kim KJ, Lee JY. Trends in antiepileptic drug prescriptions for childhood epilepsy at a tertiary children’s hospital in Korea, 2001-2012. Pediatr Drugs. 2015;17(6):487-96.

9. Putignano D, Clavenna A, Campi R, Bortolotti A, Fortino I, Merlino L, et al. Antiepileptic drug use in Italian children over a decade. Eur J Clin Pharmacol. 2017;73(2):241-8.

10. Balagura G, Iapadre G, Verrotti A, Striano P. Moving beyond sodium valproate: choosing the right anti-epileptic drug in chil-dren. Expert Opin Pharmacother. 2019;20(12):1449-56.

11. Thomas LH, Cullum NA, McColl E, Rousseau N, Soutter J, Steen N. Guidelines in professions allied to medicine. Cochrane Database Syst Rev. 1999;(1):CD000349.

12. Lugtenberg M, Burgers JS, Westert GP. Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Qual Saf Health Care. 2009;18(5):385-92.

13. Grol R, Wensing M, Eccles M, Davis D. Improving patient care: the implementation of change in health care. 2nd ed. Chichester: Wiley-Blackwell; 2013.

14. Sauro KM, Wiebe S, Perucca E, French J, Dunkley C, de Marinis A, et al. Developing clinical practice guidelines for epilepsy: a report from the ILAE Epilepsy Guidelines Working Group. Epilepsia. 2015;56(12):1859-69.

15. Jetté N, Kirkpatrick M, Lin K, Fernando SMS, French JA, Jehi L, et al. What is a clinical practice guideline? A roadmap to their development. Special report from the Guidelines Task Force of the International League Against Epilepsy. Epilepsia. 2022;63(8):1920-9.

16. National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. London: NICE; 2022. (NICE guideline NG217).

17. Leviton A, Patel AD, Loddenkemper T. Self-management education for children with epilepsy and their caregivers. A scoping review. Epilepsy Behav. 2023;144:109232.

Published

2026-03-28

How to Cite

1.
Eltahir S, Babikir H, Eldin IT. Impact of Clinical Pharmacist led-Educational program on Knowledge and Practice of Sudanese Pediatricians About Management of Epilepsy in Children. AIM [Internet]. 2026 Mar. 28 [cited 2026 May 13];4(1). Available from: https://journals.eikipub.com/index.php/AIM-Medicine/article/view/790